CoChat

Dietary docosahexaenoic acid (DHA) as lysophosphatidylcholine, but not as free acid, enriches brain DHA and improves memory in adult mice

Open access
Sugasini, Dhavamani, Thomas, Riya, Yalagala, Poorna C. R., Tai, Leon M., Subbaiah, Papasani V. · 2017 · Scientific Reports

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Docosahexaenoic acid (DHA) is uniquely concentrated in the brain, and is essential for its function, but must be mostly acquired from diet. Most of the current supplements of DHA, including fish oil and krill oil, do not significantly increase brain DHA, because they are hydrolyzed to free DHA and are absorbed as triacylglycerol, whereas the transporter at blood brain barrier is specific for phospholipid form of DHA. Here we show that oral administration of DHA to normal adult mice as lysophosphatidylcholine (LPC) (40 mg DHA/kg) for 30 days increased DHA content of the brain by >2-fold. In contrast, the same amount of free DHA did not increase brain DHA, but increased the DHA in adipose tissue and heart. Moreover, LPC-DHA treatment markedly improved the spatial learning and memory, as measured by Morris water maze test, whereas free DHA had no effect. The brain derived neurotrophic factor increased in all brain regions with LPC-DHA, but not with free DHA. These studies show that dietary LPC-DHA efficiently increases brain DHA content and improves brain function in adult mammals, thus providing a novel nutraceutical approach for the prevention and treatment of neurological diseases associated with DHA deficiency, such as Alzheimer's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-11766-0

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Proposed hypothesis. When dietary DHA is present in TAG (for example, fish oil) or in sn-2 position of PC (for example, krill oil), it is released as free fatty acid and absorbed as TAG in the chylomicrons. On the other hand, if DHA is provided in sn-1 position of PC, or as LPC, it will be absorbed as PC in chylomicrons and HDL. The PC-DHA is more likely to be transported into brain after conversion to LPC, compared to TAG-DHA, since the brain preferentially takes up DHA as LPC.
Figure 1 Proposed hypothesis. When dietary DHA is present in TAG (for example, fish oil) or in sn-2 position of PC (for example, krill oil), it is released as free fatty acid and absorbed as TAG in the chylomicrons. On the other hand, if DHA is provided in sn-1 position of PC, or as LPC, it will be absorbed as PC in chylomicrons and HDL. The PC-DHA is more likely to be transported into brain after conversion to LPC, compared to TAG-DHA, since the brain preferentially takes up DHA as LPC.CC BY · PubMed Central
Figure 2 Effect of molecular carrier of dietary DHA on plasma levels (% of total fatty acids) of 22:6 (A), and 20:4 (B), on 22:6/20:4 ratio (C), and on LPC-DHA (µg/ml) (D). Results shown are mean ± SD (n = 8). Bars in each panel not sharing a common superscript are significantly different from each other (p < 0.05, one way ANOVA, and post-hoc Tukey test).
Figure 2 Effect of molecular carrier of dietary DHA on plasma levels (% of total fatty acids) of 22:6 (A), and 20:4 (B), on 22:6/20:4 ratio (C), and on LPC-DHA (µg/ml) (D). Results shown are mean ± SD (n = 8). Bars in each panel not sharing a common superscript are significantly different from each other (p < 0.05, one way ANOVA, and post-hoc Tukey test).CC BY · PubMed Central
Figure 3 Effect of molecular carrier of dietary DHA on the concentrations of 22:6 and 20:4, and on 22:6/20:4 ratio in liver, heart and adipose tissue. The values shown are mean ± SD (n = 8). Bars in each panel without common superscripts are significantly different from each other (p < 0.05, one way ANOVA, followed by post-hoc Tukey test).
Figure 3 Effect of molecular carrier of dietary DHA on the concentrations of 22:6 and 20:4, and on 22:6/20:4 ratio in liver, heart and adipose tissue. The values shown are mean ± SD (n = 8). Bars in each panel without common superscripts are significantly different from each other (p < 0.05, one way ANOVA, followed by post-hoc Tukey test).CC BY · PubMed Central
Figure 4 Effect of dietary treatment with free DHA, sn-1 DHA LPC, and sn-2 DHA LPC on the levels of 22:6 and 20:4 and on the 22:6/20:4 ratios in various regions of the brain. The values shown are mean ± SD (n = 8, for all regions, except for Amygdala, where n = 6). The bars in each figure not sharing common letter are significantly different from each other (p < 0.05, one way ANOVA, and post-hoc Tukey test).
Figure 4 Effect of dietary treatment with free DHA, sn-1 DHA LPC, and sn-2 DHA LPC on the levels of 22:6 and 20:4 and on the 22:6/20:4 ratios in various regions of the brain. The values shown are mean ± SD (n = 8, for all regions, except for Amygdala, where n = 6). The bars in each figure not sharing common letter are significantly different from each other (p < 0.05, one way ANOVA, and post-hoc Tukey test).CC BY · PubMed Central
Figure 5 Effect of dietary free DHA, sn-1 DHA LPC, and sn-2 DHA LPC on the DHA concentration in various regions of brain, expressed as nmol/mg tissue. The values shown are n = 8, for all regions, except for Amygdala, where n = 6. Bars with non-identical letters on top are significantly different from each other in each panel (p < 0.05, one way ANOVA, and post-hoc Tukey test).
Figure 5 Effect of dietary free DHA, sn-1 DHA LPC, and sn-2 DHA LPC on the DHA concentration in various regions of brain, expressed as nmol/mg tissue. The values shown are n = 8, for all regions, except for Amygdala, where n = 6. Bars with non-identical letters on top are significantly different from each other in each panel (p < 0.05, one way ANOVA, and post-hoc Tukey test).CC BY · PubMed Central
Figure 6 Improved memory in mice treated with LPC DHA compared to control or free DHA treated mice. In study 1 (A and B), Morris water maze tests of mice treated with vehicle (control), free DHA, sn-1 DHA LPC, and sn-2 DHA LPC for 1 month are shown. LPC DHA-treated mice did not differ from control or free DHA mice in the acquisition phase (A). In the probe trial (B) both sn-1 DHA LPC and sn-2 DHA treated mice reached the previous platform area with shorter latency time, and spent longer in the target quadrant. Data expressed as mean ± S.D (n = 8). *p < 0.05, by two-way ANOVA followed by Tukey’s post hoc comparisons. In a second study (C and D) to validate the above results, only 2 groups of mice were used and were treated either with free DHA or sn-1 DHA LPC for 1 month. As in the first study, sn-1 DHA LPC treated mice reached the previous platform area with a lower latency time, and spent longer in the target quadrant, compared to free DHA group (n = 5 each). Data are expressed as mean ± S.D. *p < 0.05 by two-way ANOVA followed by Tukey’s post hoc comparisons.
Figure 6 Improved memory in mice treated with LPC DHA compared to control or free DHA treated mice. In study 1 (A and B), Morris water maze tests of mice treated with vehicle (control), free DHA, sn-1 DHA LPC, and sn-2 DHA LPC for 1 month are shown. LPC DHA-treated mice did not differ from control or free DHA mice in the acquisition phase (A). In the probe trial (B) both sn-1 DHA LPC and sn-2 DHA treated mice reached the previous platform area with shorter latency time, and spent longer in the target quadrant. Data expressed as mean ± S.D (n = 8). *p < 0.05, by two-way ANOVA followed by Tukey’s post hoc comparisons. In a second study (C and D) to validate the above results, only 2 groups of mice were used and were treated either with free DHA or sn-1 DHA LPC for 1 month. As in the first study, sn-1 DHA LPC treated mice reached the previous platform area with a lower latency time, and spent longer in the target quadrant, compared to free DHA group (n = 5 each). Data are expressed as mean ± S.D. *p < 0.05 by two-way ANOVA followed by Tukey’s post hoc comparisons.CC BY · PubMed Central
Figure 7 BDNF levels in the brain regions of mice treated with various molecular carriers of dietary DHA. Values shown are mean ± SD (n = 6). Bars with non-identical letters are significant from each other by one way ANOVA, and post-hoc Tukey test.
Figure 7 BDNF levels in the brain regions of mice treated with various molecular carriers of dietary DHA. Values shown are mean ± SD (n = 6). Bars with non-identical letters are significant from each other by one way ANOVA, and post-hoc Tukey test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 47 references

Cited by

See all 224

Metadata

Authors
Sugasini, D., Thomas, R., Yalagala, P. C. R., Tai, L. M., & Subbaiah, P. V.
Affiliations
University of Illinois Chicago (US)
Corresponding author
Subbaiah, Papasani V.
Venue
Scientific Reports
Published
2017-09-12
Volume
7
Issue
1
Pages
11263-11263
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2753001826
Cited by
201
References
47
Citations by year
2026: 29 · 2025: 20 · 2024: 19 · 2023: 18 · 2022: 28 · 2021: 29 · 2020: 21 · 2019: 20 · 2018: 14 · 2017: 3
FWCI
13.19
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Veterans Affairs (S10 OD010660, BX001090, I01 BX001090, IO1 BX001090)
  • National Institutes of Health (1s10od010660-01a1, IO1 BX001090)
  • NIH Office of the Director (S10 OD010660)
  • National Center for Complementary and Integrative Health (R21AT008457)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
docosahexaenoic acid, lysophosphatidylcholine, spatial learning and memory, brain-derived neurotrophic factor, blood-brain barrier, nutraceuticals, Alzheimer's disease, adipose tissue, heart
MeSH terms
Animals, Ascorbic Acid, Brain, Brain Chemistry, Docosahexaenoic Acids, Lysophosphatidylcholines, Memory, Dietary Supplements, Mice, Spatial Learning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dietary docosahexaenoic acid (DHA) as lysophosphatidylcholine, but not as free acid, enriches brain DHA and improves memory in adult mice. https://app.cochat.ai/papers/10.1038/s41598-017-11766-0
The paper
Sugasini, D., Thomas, R., Yalagala, P. C. R., Tai, L. M., & Subbaiah, P. V. (2017). Dietary docosahexaenoic acid (DHA) as lysophosphatidylcholine, but not as free acid, enriches brain DHA and improves memory in adult mice. Scientific Reports. https://doi.org/10.1038/s41598-017-11766-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.